Earlier Repletion of Lymphocytes After Alemtuzumab Induction Is Associated with a Lower Incidence of Infection Following Renal Transplantation.

被引：0
|
作者：
Willicombe, M. [1 ]
Goodall, D. [1 ]
McLean, A. [1 ]
Taube, D. [1 ]
机构：
[1] Hammersmith Hosp, Imperial Coll, Renal & Transplant Ctr, London, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
223
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [21] INCIDENCE OF MALIGANCY AFTER KIDNEY TRANSPLANTATION WITH ALEMTUZUMAB AND OTHER INDUCTION AGENTS
    Nepal, Manish
    Al-laham, Ammar
    Wood, Craig
    Govindasamy, Rajesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A72 - A72
  • [22] Long Term Follow-Up of Alemtuzumab vs Thymoglobulin Induction in Renal Transplantation.
    Powderly, A.
    Truscott, C. B.
    Feurer, I.
    Karp, S. J.
    Shaffer, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 319 - 319
  • [23] Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation - a retrospective study
    Willicombe, Michelle
    Goodall, Dawn
    McLean, Adam G.
    Taube, David
    TRANSPLANT INTERNATIONAL, 2017, 30 (11) : 1110 - 1118
  • [24] The Incidence, Nature and Risk Factors for Stroke Following Renal Transplantation.
    Willicombe, M.
    Kumar, N.
    Chan, K.
    Galliford, J.
    McLean, A.
    Duncan, N.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 429 - 429
  • [25] Steroid Sparing Regimes Are Not Associated with a High Incidence of Recurrent Disease after Renal Transplantation.
    Chan, K.
    Lawrence, C.
    Charif, R.
    McLean, A.
    Cairns, T. D. H.
    Cook, T.
    Roufosse, C.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 513 - 513
  • [26] Renal Allograft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.
    Gallon, L.
    Mathew, J.
    Bontha, S.
    Dumur, C.
    Dalal, P.
    Nadimpalli, L.
    Maluf, D.
    Shetty, A.
    Ildstad, S.
    Leventhal, J.
    Mas, V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 620 - 620
  • [27] Fungal and mycobacterial infections after Campath (alemtuzumab) induction for renal transplantation
    Walsh, R.
    Ortiz, J.
    Foster, P.
    Palma-Vargas, J.
    Rosenblatt, S.
    Wright, F.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (04) : 236 - 239
  • [28] Infectious complications after renal transplantation utilizing alemtuzumab induction.
    Walker, Jennifier K.
    Afaneh, Cheguevara I.
    Gallon, Lorenzo G.
    Kaufman, Dixon B.
    Stosor, Valentina
    Ison, Michael G.
    Leventhal, Joseph R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 503 - 504
  • [29] Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction
    Walker, Jennifer K.
    Scholz, Lisa M.
    Scheetz, Marc H.
    Gallon, Lorenzo G.
    Kaufman, Dixon B.
    Rachwalski, Erik J.
    Abecassis, Michael M.
    Leventhal, Joseph R.
    TRANSPLANTATION, 2007, 83 (07) : 874 - 882
  • [30] Lower Incidence of New Onset Diabetes after Cardiac Transplant with Alemtuzumab Induction
    Jones, R.
    Shullo, M. A.
    Zomak, R.
    Newman, C.
    Rebel, M.
    Yost, C.
    Navoney, M.
    McNamara, D. M.
    Toyoda, Y.
    Kormos, R. L.
    Teuteberg, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S104 - S104
12345